NovaBay Global Ophthalmology Study Enrolls First Patients in Brazil
[at noodls] – Press Releases EMERYVILLE, CA – April 8, 2013 BAYnovation Phase 2b Trial for the Treatment of Viral Conjunctivitis Spans Three Continents NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology … more
View todays social media effects on NBY
View the latest stocks trending across Twitter. Click to view dashboard